What Cannabinoids and Terpenes Can Do for You

https://www.learngreenflower.com/video-2-understanding-cannabinoids-and-terpenes

This video is great basic knowledge on cannabinoids and terpenes. It explains why Cannabis is such a huge breakthrough discovery in medical efficacy – and it is safe to use. It becomes available as drug free deep frozen pressed hemp juice (with very low THC) or as deep fozen pressed medical cannabis juice with THC higher than 0.3% in the dry plant material.

The beauty of hemp juice or cannabis juice is

  • you can drink it raw as it is delivered deep frozen with THC-A and CBD-A
  • you can heat it and activate the cannabinoids into THC and CBD
  • you can enjoy the entire matrix of cannabinoids and terpenes in a pressed juice
  • you get the benefit of all proteins and vital nutrients in the plant
  • you get controlled quality from producers with patent license

(The only legal juice is from producers with a patent license carrying the seal GREEN SNAKE (reg. trademark). GREEN SNAKE wants contact to growers and prospective producers to share know how and patent license in Europe, the US, Canada, China, Brazil. This remark on behalf of GREEN SNAKE inventors of pressed hemp and cannabis juice I gladly share to help bring this amazing health food to everyone in need!)

Happy hemping everyone

Freeze-drying hemp juice may lower CBD / CBD-A content considerably

High CBD / CBD-A content in frozen hemp juice may not lead to high content in freeze-dried hemp juice powder found in capsules on the market. We have made several tests on different devices to freeze-dry hemp juices. Subsequent lab analysis shows disappointing results. Freeze-drying reduces the hemp juice to a dry powder of 1/10 to 1/15 of the original weight of the juice. The powder is easy to handle, to transport and to store. However, these advantages are outweighed by very poor Cannabinoid results. The CBD / CBD-A as well as the THC / THC-A contents in the powder are no way near the amounts one would expect due to the concentration of juice into powder.

Consumers who are disappointed not to see comparable results from hemp juice powder capsules than they experienced from frozen hemp juice may want to revert back to using the juice itself. There are, however, ways to increase the CBD effectively.

  • by using as much as a teaspoon full of powder instead of 1 capsule per day, but that turns out to be exceedingly costly…
  • by treating the hemp juice a certain natural way before freeze drying it

Claremont-Collection GmbH, Hamburg, shares it’s know-how on the patented process to pressing hemp juice

Hemp Juice Lady is all for quality control and consumer protection in a new market. What is happening in the CBD-extract market must not happen to the hemp juice market! There are global patents in place to regulate the manufacturing of true GreenSnake® hemp juice. The registered seal of GreenSnake® aims to protect consumers through quality standards and legality. The seal may be displayed only by those producers who have entered into license agreements with the owners of the hemp juice patents. Those producers thereby share the rich knowledge base of the inventors of pressing the hemp plant into hemp juice and to process this juice.

 

CBD News – International Cannabinoid Research Society 2016

CBD News from the International Cannabinoid Research Society 

297 scientists met in Poland June 2016 to share their research results on cannabinoids. I want to share some with you.

STROKE: CBD reduces brain damages in animals after a stroke.

NEUROPATHIC PAIN TREATMENT: THC and CBD work synergistically.

CANCER: CBD potentiates Big pharma meds effect in prostate cancer and induces death in myeloma cancer cells.

BLOOD PRESSURE: in animals is reduced by CBD.

LEAKY GUT: CBD protects against intestinal permeability caused by stress.

ALZHEIMER’S:CB2 cannabinoid receptors are active when reversing memory loss and neuro-inflammation.

Anandamide is a main endo-cannabinoid helping to maintain homeostasis. The other principal cannabinoid is 2AG, important in stress resilience.

DIET has important impact on the endo-cannabinoid system. Eat fresh.

OLD: cannabis pollen found in Tibet is almost 20 million years old.

CANNABIS RESEARCH: led to the discovery of a “hitherto unknown biochemical communication system in the human body, the endo-cannabinoid system”.

 

The ICRS has teamed up with Mary Ann Liebert, Inc. Publishers to bring you Cannabis and Cannabinoid Research – an open access journal for the cannabinoid sciences.

Hemp CBD buffer: homeostatic regulator

 

Dr. Ethan Russo, neurologist, medical scientist, and former senior medical advisor at GW Pharma discusses CBD as homeostatic regulator and the endocannabinoid system in conversation with Cannabis Conversations (Project CBD).

Dr.Russo is the medical research director at Phytecs, a biotechnology company with a research focus on the endocannabinoid system. Which explains his focus on the homeostasis created by Cannabinoids.
Their aim is to target the endocannabinoid system directly to target any existing deficiencies within the body and subsequent diseases. They are also looking for non-drug herbal approaches.

 

  1. Homeostasis

If you want to make yourself familiar with the benefits of cannabinoids (produces NO INTOXICATION, anti-anxiety, anti-psychotic, anti-inflammatory etc.) check out this post.

So first things first, in case you are not familiar with what the endocannabinoid system (ECS) is, here we go:

Cannabinoids = from plants

Endocannabinoids = produced by mammals in their bodies

The ECS It is the body’s own cannabinoid system. Meaning, every mammal has their own receptor system for endocannabinoids and cannabinoids within their bodies as well as creates endocannabinoids within their body. Cannabinoids from plants can bind to those receptors within our bodies. Cannabinoids find receptors in the nervous and immune system.

-There are more receptors in our human brain for cannabinoids than for all other neurotransmitters together.-

So Dr. Russo states that cannabidiol is an endocannabinoid modulator and therefore a homeostatic regulator. This is the reason cannabinoids work for so many diseases which affect different parts of our bodies.

Homeostasis = state of balance and health

Bi-directional effect of CBD = CBD acts as buffer, balances either excess or deficiency in system

What he means by that is that the bi-directional effect of CBD, which always works to create a balance no matter if there is currently a deficiency or an excess, always works toward creating a homeostasis (balance and health).

CBD regulates neurotransmitter functions, it simply does so as a consequence of the imbalance.
CBD needs to be seen as a universal tool, it is not able to only fix one certain issue within our body but every issue that has arisen from an imbalance.

CBD is a regulator for any given issue within the body. Not just a specific one, which makes it incredibly versatile.

“The endocannabinoid system one of its main roles in the brain is to regulate neurotransmitter function and again, if there’s too much of one kind of neurotransmitter it will bring it down, if there’s too little it will bring it up.”

CBD can be seen as a tool within the body that does not target one specific ailment within the system but rather aims to act as a buffer tool and balance out any imbalance which creates problems in our bodies.

 

2Y9A8114-006

2. Clinical Endocannabinoid Deficiency

This discovery has led Dr.Russo to the clinical endocannabinoid deficiency theory.

He has found out that diseases such as migraine, irritable bowel syndrome (IBS), and fibromyalgia all have a characteristics in common: they all have disproportionate levels of pain although tissues look ok. Moreover, these diseases tend to occur in the same people, someone who already suffers from migranes is more likely to suffer from IBS later in life. And studies show people suffering from those diseases have endocannabinoid deficiencies.

 

3. Food and Cannabinoid receptors

There are food ingredients which act on cannabinoid receptors, for instance caryophellene. He makes an important point regarding already existing examples of components of common foods which impact the endocannabinoid system.

Dr. Russo states the following regarding black pepper:

“The advantage of an agent that would act on CB2 receptors would be reducing inflammation, reducing pain, but without psychoactive side effects. Now as it turns out this caryophellene is very selective there. It’s a very safe agent. This, for example, is in black pepper. It’s called GRAS by the government – not that kind of grass – rather GRAS, Generally Recognized As Safe as a food additive. So this is something with the government’s seal of approval. It’s in our diet. But more of this would certainly have a positive influence on health, particularly for people with arthritis or other kinds of chronic pain. And again, without any liability in terms of having unwanted side effects.”

Foto by Fotolia • Lukas Gojda • 72634215

4. The Entourage Effect

Another aspect mentioned by Dr.Russo is the importance of the phyto-synergy of the ingredients.

Caryophellene in black pepper is an important example of how we can deal with CBD as food. Particularly in the debate whether CBD belongs to the pharma industry or the food and beverage market.

CBD tends to get isolated through extraction these days.

Yet, Dr.Russo stresses the importance of the entourage effect and the effect the whole plant mixture has in comparison to isolated CBD molecules.

The transcript of the full interview can be found here.

Happy hemping everyone!

Größte EIHA Nutzhanf Konferenz aller Zeiten – Mark Reinders neuer Präsident

300 Teilnehmer aus 42 Ländern trafen sich Anfang Juni in Wesseling bei Köln zum Austausch der neuesten Daten und Entwicklungen, Diskussionen, Strategien und Netzwerken der weltweiten Hanfindustrie. Kann Nutzhanf in Europa bis 2030 eine Anbaufläche von 100.000 ha erreichen? Mark Reinders von der holländischen Firma HempFlax B.V. wurde zum neuen Präsidenten der “European Industrial Hemp Association (EIHA)” gewählt.

Produktion von Hanfnüssen von 2010 bis 2013 um 92%, Produktion von Blüten und Blättern sogar um 3.000% gestiegen

Die Anbauflächen von Nutzhanf in Europa, die Investitionen, und die Nachfrage nach Hanfprodukten wachsen in Europa und weltweit kontinuierlich an. Zwischen den Jahren 2011 und 2015 haben sich die Anbauflächen für Hanf in der Europäischen Union verdreifacht.

Hanflebensmitteln sehen das größte Wachstum. Die Produktion von Hanfnüssen stieg von 2010 bis 2013 um 92%, die Produktion von Blüten und Blättern sogar um unglaubliche 3.000%.

Auf der Konferenz war eine inspirierte und optimistische Atmosphäre zu spüren und die wichtigste Frage war, wie kann man den Anbau und die Verarbeitung von Hanf ausbauen, um die wachsende Nachfrage zu befriedigen?

Wird es gelingen, die Anbaufläche von 25.000 ha im letzten Jahr auf 100.000 ha im Jahr 2025 oder 2030 anzuheben? Wie viele neue Arbeitsplätze würden dabei entstehen? Wie viele Treibhausgas-Emissionen könnten durch die Substitution weniger umweltfreundlicher Produkte eingespart werden? Wie schnell werden Hanflebensmittel großvolumige Mainstream-Lebensmittel werden? Wie kann der Zugang zu CBD geregelt werden, so dass Patienten ihre Medizin bekommen, aber auch gesundheitsbewusste Menschen CBD-haltige Produkte zu sich nehmen können?

Einen Tag vor der Konferenz organisierte die “European Industrial Hemp Association (EIHA)“ einen ganzen Tag mit Sitzungen, darunter auch die Vollversammlung des Vereins. Nach elf Jahren Präsidentschaft legte John Hobson, GW Research, sein Amt als Präsident und Vorstandsmitglied nieder. Die Mitglieder bedankten sich bei John Hobson für seine exzellente Arbeit. Mark Reinders vom holländischen Unternehmen HempFlax B.V., ein Pionierunternehmen für Anbau und Verarbeitung von Hanf in den Niederlanden und Rumänien, wurde mit 86% der Stimmen zum neuen Präsidenten gewählt. Sylvestre Bertucelli von InterChanvre, dem französischen Industriehanfverband, wurde mit 93% der Stimmen zum Stellvertreter gewählt. Und schließlich wurde Boris Baňas von Propaganda Production s.r.o. (Slovakia) mit 90% de Stimmen zum neuen Vorstandsmitglied gewählt.

In unsicheren ökonomischen Zeiten ist es sehr bestärkend, die Wachstumsperspektiven der europäischen Hanfindustrie vor Augen geführt zu bekommen.

EIHA Vorstandsmitglieder:

Nova Institut

Fotoreportage

picture©: nova-Institut

Daniela Sfrija (CANAH International SRL (Romania)), Boris Banas (PROPAGANDA PRODUCTION s.r.o (Slovakia)), Mark Reinders (HempFlax B.V. (The Netherlands)), Daniel Kruse (Hempro Int. GmbH & Co. KG (Germany)), Olivier Moreau (CAVAC BIOMATERIAUX (France)), Sylvestre Bertucceli (Interchanvre (France)), Bernd Frank (Planete Chanvre (France)) (v.l.n.r.)

Mehr Informationen zum Thema: www.eiha-conference.org

Source: nova-Institut, Pressemitteilung, 2016-06-09.

 

Happy hemping everyone!

Sign the Medical Cannabis Declaration (MCD)

 

The Declaration of Human Rights for Medical Access to Cannabis and Cannabinoids states the following:

“According to the Universal Declaration of Human Rights adopted by the  United Nations in 1948:

“Everyone has the right to life, liberty and security of person”  (Article 3).

“Everyone has the right to a standard of living adequate for the  health and well-being of himself and of his family, including food,  clothing, housing and medical care and necessary social services, and  the right to security in the event of unemployment, sickness,  disability, widowhood, old age or other lack of livelihood in  circumstances beyond his control” (Article 25, Paragraph 1).

Whereas this Declaration applies to everyone and all people, whereas  many doctors are banned by legal requirements from treating their  patients with cannabis-based medicines and whereas many people cannot  afford access to cannabis-based drugs we thus declare that:

1. Every medical doctor has the right to treat his or her patients with cannabinoids and cannabis products according to the rules of  good medical care.
2. Every patient has the right to access cannabis and cannabinoids for medical treatment supervised by a medical doctor, regardless of  social status, standard of living or financial means.”

 

The MCD is already signed by nearly 4.700 people.

 

Sign the Medical Cannabis Declaration here.

 

Happy hemping everyone!

 

 

Hemp clothing in Hamburg – Marlowe Nature

Marlowe Nature in Hamburg Eimsbüttel (Beim Schlump 9) now also stores fashionable and ecologically friendly hemp mens wear.

Happy hemping everyone!
drugfree cannabis plant

Hemp and the pharmaceutical industry – and in the middle the EU

Big companies rule the the EU through lobbyism, as I can tell from own experience.

I have discovered through research that the cannabis plant, especially industrial hemp is also food and contains an extensive amount of nutrients, for instance all essential proteins and omega fatty acids.
Until now, the carriers of these valuable nutrients, namely the leaves and leafy blossoms have been wasted and simply left on the field during retting.
It was already common knowledge that industrial hemp also contains valuable health ingredients, the cannabinoids – yet never seen as food.

The pharmaceutical industry has an eye on these valuable cannabinoids and wants to make sure they are classified as a pharmaceutical and not as a freely available plant ingredient.

The pharmaceutical lobby soon began to spread the message that cannabis was a dangerous drug which if anything could only be turned into something positive and useful by the pharmaceutical industry.

Politicians who were not able to distinguish between high THC levels in marijuana and low levels of THC in industrial hemp soon began to pass everything that contained any THC whatsoever over to pharmaceutical companies.

This is how the whole legalization fight emerged – it is once again simply a matter of profit for the big pharma players.

Nobody even considered making the valuable nutrients in industrial hemp available to humans.

Only my invention brought about this idea that hemp is food. My invention is to press raw hemp juice which contains ALL healthy naturally occurring ingredients of the hemp plant to be consumed by humans.

Since the juice production also yields press remnants which contain the hard to digest fibers of the plant, nutritious cattle feed would also be an additional value created when producing the juice.

I got this invention patented in order to ensure the pharmaceutical industry would not get a hold of this new discovery and could therefore not restrict the wider general public from access to this healthy nutrition.

As a member of the European Industrial Hemp Association I sadly have to witness with many other enthusiastic hemp advocates that the the pharmaceutical industry is currently working hard on Brussels to restrict the free access and right to process industrial hemp as a food.
Their aim is to exclusively handle Cannabinoids and use it in medicine. Therefore, they are trying to get single cannabinoids patented and now claim everything that contains these patented cannabinoids, such as CBD or THC, cannot be categorised as food but as a pharmaceutical.

This claim is equally grotesque as claiming lemons could only be used as medicine due to the vitamin C they contain or tomatoes are medicine because of the glutamate they contain.

Tomatoes contain within their matrix of natural ingredients a substance called glutamic acid or glutamate, a common neurotransmitter. However, this does not make a tomato a medicinal product, or a pharmaceutical prescription drug or subject to governmental permission. Glutamate, since it was discovered in tomatoes, did not even make it a novel food. The level of glutamic acid in tomatoes is not monitored either.

It looks like bureaucrats in Brussels do not invest enough time into gathering information, hence they simply rely on information provided by the pharma lobby itself.

We would be better off if every country within the EU would decide for itself. Specialized politicians, under democratic control, would then debate a EU wide solution.

A result of this would be a more transparent process as opposed to the current process in Brussels. In which big corporations and their lobbyists are breathing down EU bureaurats necks in order to dictate that except for hemp seeds nothing else of the hemp plant shall be food for general consumption. This happens far off from any direct nation-state supervision or monitoring.

drugfree cannabis plant

Hanf und die Pharmaindustrie – mittendrin die EU

Ich kann aus eigener Erfahrung bestätigen, dass die großen Konzerne die EU “regieren”.
Mein Fall: ich habe durch Forschung herausgefunden, dass die Pflanze Cannabis bzw. der drogenfreie Hanf als Lebensmittel sehr viele wichtige Nährstoffe enthält. z.B. alle Proteine.
Bisher waren die Träger dieser wertvollen Inhaltsstoffe, die Blätter und oberen Blütenstände auf dem Feld geblieben – verschwendet. Es war schon bekannt, dass auch im drogenfreien Hanf außerdem sehr wertvolle Gesundheitsstoffe sind, die Cannabinoide – jedoch nicht als Lebensmittel.

Die Pharmaindustrie hatte bereits ihre Hände darauf gelegt und wollte Cannabinoide nicht frei zugänglich den Menschen überlassen. Ihre Lobby Maschinerie setzte bald in die Welt, Cannabis, das sei eine gefährliche Droge, aus der allenfalls die Pharmaindustrie etwas Gutes machen könne.
Die Politiker, die den Unterschied zwischen hohen THC Gehalten im Cannabis und niedrigen THC Gehalten im Hanf nicht zu unterscheiden wußten, fingen plötzlich an, alles, was THC enthält der Pharmaindustrie zu überlassen. Deshalb der ganze Legalisierungskampf, es geht mal wieder ums Geld für die Großkonzerne.

Niemand kümmerte sich darum, die Nährstoffe aus dem Industriehanf (im Gegensatz zum High produzierenden Cannabis) für den Menschen zugänglich zu machen. Erst meine Erfindung machte das möglich. Aus dem Hanf den Saft zu pressen, in dem ALLE Inhaltsstoffe die Nahrung und auch die anderen gesunden Stoffe enthalten ist.
Als Pressreste mit den schwerverdaulichen Ballaststoffen blieb auch für die Kühe etwas Nahrhaftes übrig.

Diese Erfindung ließ ich patentieren, ich wollte sie auf keinen Fall der Pharmaindustrie überlassen. Ich bin Mitglied der EIHA, der Europäischen Industrie-Hanf Association. Zusammen mit anderen, die den Nährwert des Hanfes unter die Menschen bringen wollen, müssen wir feststellen, dass in Brüssel die Pharmaindustrie dabei ist, uns den freien Zugang zur Nahrungs-Verwertung von Industrie-Hanf zu verbauen. Nur sie will die Cannabinoide zu Medizin verarbeiten können.

Die Pharmaindustrie will ein einzelnes Cannabinoid patentieren lassen und behauptet nun, überall wo dieses Cannabinoid drin sei, handele es sich nicht um Nahrung, sondern um Medizin.Das ist genauso schwachsinnig wie zu behaupten, die Zitronen dürften nur noch zu Medizin verarbeitet werden, weil sie Vitamin C enthalten, oder die Tomaten seien Medizin, weil sie Glutamat enthalten.

Doch die Brüsseler Bürokraten scheinen es zu verpassen sich schlau zu machen und verlassen sich nur allzu gerne auf die Einflüsterungen der Pharmalobby. Das wäre so gar nicht möglich, wenn wir in jedem Land einzeln die Bestimmungen machten. Die Fachpolitiker aus allen Ländern können sich ja dann miteinander eine gemeinsame Europäische Lösung überlegen.
Das wäre transparenter als der undemokratische Brüsseler Apparat, in dem fernab jeder direkten Länderkontrolle die Einflussnahme der Lobbyisten blüht, weil nur die Großkonzerne den EU Markt bestimmen wollen und ihn somit einfach kaufen.

Continuous growth of the European hemp industry

Nova Institut

EIHA 2016 conference in Cologne, Wesseling. Picture: nova-Institut©

Continuous growth of the European hemp industry

Immense demand for hemp as a food and pharmaceutical

The industrial association „European Industrial Hemp Association (EIHA)“ presents the newest data on hemp cultivation, processing and applications for fibres, shivs, seeds and flowers. From the year 2011 to 2015 the cultivation area in the European Union more than tripled to 25,000 ha.

The cultivation of industrial hemp was legalised in most EU member states between 1993 and 1996.

Hemp is a multi-purpose crop, delivering fibres, leaves, shivs and seeds.

  • Hemp Juice contains all the important naturally occuring ingredients of the hemp plant in the original shape as present in the hemp plant itself.This is due to the fact that the juice pressing procedure simply separates all the fluid in the plant from the press cake, so separated solids and fluids.This is necessary because the hemp plant is very high in fiber which makes processing the whole plant in a blender a lot less suitable for human consumption as it will upset the human stomach quite a lot as the fibers are not easily digestable.

    So the result of the juice pressing is a hemp juice which contains all the ingredients of the hemp plant in an entourage effect if pressed with the patented GreenSnake® hemp juice procedure. The hemp juice contains up to 300mg of CBD per 100 ml juice, this equals 11 kg CBD per 1ha industrial hemp.

    The juice and the press cake contain all Cannabinoids of the hemp plant, not just CBD.

    Moreover, the juice pressing procedure produces a press cake which can be further used for instance to produce CBD extracts, hemp protein powder or animal feed.

    This press cake contains an additional 6kg CBD per 1 ha industrial hemp.

  • Hemp fibers can be used for hemp paper and hemp insulation material.
  • Hemp shivs (woody inner core of the stem) can be used as animal bedding or for hempcrete as building material.
  • Hemp seeds (or hemp nuts) can be eaten raw or toasted, or be pressed into hemp seed oil or used as animal feed. Hemp seeds are already being praised as new super food.

The new report  „The European Hemp Industry: Cultivation, processing and applications for fibres, shivs, seeds and flowers” portrays the development of the European industrial hemp industry between 2010 and 2013.In 2015 Europe had 25.000 ha of hemp, still will increase even further. Main growers so far are France, the Netehrlands as well as Romania.

Many of the new EU member states are putting a particular focus on industrial hemp as an economic booster, especially for the trade of hemp seeds. Hemp seed production rose by 92 % between 2010 and 2013. Production of flowers and leaves rose even more by a staggering 3.000 % in the same time. This is in contrast to fiber and shivs which do not show any significant rise in growth or use between 2010 and 2013.

The report “The European Hemp Industry: Cultivation, processing and applications for fibres, shivs, seeds and flowers” was presented for the first time at the “13th International Conference of the European Industrial Hemp Association”, 1 – 2 June 2016, Wesseling near Cologne (Germany), the meeting point of the hemp industry worldwide (www.eiha-conference.org). More than 295 participants from 41 countries are expected.

 

We are very pleased about the ever-growing hemp industry!

 

German version of this post available here – Deutsche Version dieses Artikels hier zu finden.

 

Happy hemping everyone!